Sood Manish M, Rigatto Claudio, Komenda Paul, Mojica Julie, Tangri Navdeep
Ottawa Hospital Research Institute, The Ottawa Hospital, Civic campus, 2-014 Administrative Services Building, 1053 Carling Avenue, Box 693, Ottawa, Ontario K1Y 4E9 Canada.
Department of Medicine, Section of Nephrology, Seven Oaks Hospital, University of Manitoba, 2300 McPhillips Street, Winnipeg, R2V 3M3 Canada.
Can J Kidney Health Dis. 2014 Jun 3;1:10. doi: 10.1186/2054-3581-1-10. eCollection 2014.
Previous reports have demonstrated similar survival for men and women on hemodialysis, despite women's increased survival in the general population.
To examine the effect of age on mortality in women undergoing chronic hemodialysis.
A retrospective cohort study using an administrative data registry, the Canadian Organ Replacement Registry (CORR) from Jan. 2001 and Dec. 2009.
Canada.
28,971 (Women 11,792 (40.7%), Men 17,179 (59.3%)) incident chronic hemodialysis patients who survived greater than 90 days on dialysis.
All-cause mortality.
Cox proportional hazards and competing risks models were employed to determine the independent association between sex, age and likelihood of all-cause mortality with renal transplantation as the competing outcome.
During the study period, 6060 (51.4%) of women and 8650 (50.4%) of men initiating dialysis died. Younger women experienced higher mortality (Age < 45: Women 22.5%, Men 18.2%, hazard ratio (HR) 1.31 (1.12-1.52)) whereas elderly women experience lower mortality (Age 75-85: Women 65%, Men 67.3%, HR 0.94 95% CI 0.88-0.99, Age > 85: Women 66%, Men 70.2%, HR 0.83 95% CI 0.71-0.97) compared to men. This relationship persisted after accounting for the competing risk of transplantation.
The cause of death was unknown.
Women's survival on chronic hemodialysis varies by age compared to men with a significantly higher mortality in women younger than 45 years old and lower mortality in woman older than 75 years of age.
既往报告显示,尽管在普通人群中女性生存率更高,但接受血液透析的男性和女性生存率相似。
研究年龄对接受慢性血液透析女性死亡率的影响。
一项回顾性队列研究,使用行政数据登记处,即2001年1月至2009年12月的加拿大器官替代登记处(CORR)。
加拿大。
28971例(女性11792例(40.7%),男性17179例(59.3%))开始接受慢性血液透析且透析存活超过90天的患者。
全因死亡率。
采用Cox比例风险模型和竞争风险模型,以肾移植作为竞争结局,确定性别、年龄与全因死亡可能性之间的独立关联。
在研究期间,开始透析的女性中有6060例(51.4%)死亡,男性中有8650例(50.4%)死亡。年轻女性死亡率更高(年龄<45岁:女性22.5%,男性18.2%,风险比(HR)1.31(1.12 - 1.52)),而老年女性死亡率低于男性(年龄75 - 85岁:女性65%,男性67.3%,HR 0.94,95%CI 0.88 - 0.99;年龄>85岁:女性66%,男性70.2%,HR 0.83,95%CI 0.71 - 0.97)。在考虑移植的竞争风险后,这种关系依然存在。
死亡原因未知。
与男性相比,接受慢性血液透析的女性生存率因年龄而异,45岁以下女性死亡率显著更高,75岁以上女性死亡率更低。